Original Article

Acta Pharmacologica Sinica (2009) 30: 113–119; doi: 10.1038/aps.2008.8; published online 8th December 2008

Insulin-like growth factor-1 promotes cell cycle progression via upregulation of cyclin D1 expression through the phosphatidylinositol 3-kinase/nuclear factor-kappaB signaling pathway in FRTL thyroid cells

Meng Ren1,#,§, Xia Zhong1,#, Chun-yan Ma1, Ying Sun2, Qing-bo Guan1, Bin Cui1, Jun Guo1, Hai Wang1, Ling Gao1 and Jia-jun Zhao1

  1. 1Shandong Provincial Hospital, Shandong University, Jinan 250021, China
  2. 2Department of Endocrinology, Yantai Yuhuangding Hospital, Yantai 264000, China

Correspondence: Dr Jia-jun Zhao, E-mail: jj_zhao61@yahoo.com.cn; Dr Ling Gao, E-mail: gaoling@medmail.com.cn

#These authors contributed equally to this work.

§Now in Department of Endocrinology, The Second Affiliated Hospital of Sun Yat-sen University, Guangzhou 510120, China.

Received 27 July 2008; Accepted 20 October 2008; Published online 8 December 2008.

Top

Abstract

Aim:

 

Insulin-like growth factor-1 (IGF-1) is an important hypertrophic and cell cycle progression factor for a number of cell types. It has been proven that IGF-1 is involved in the regulation of thyroid proliferation and cell cycle progression; however, the exact mechanism of this regulation has not been fully elucidated. In the present study, we investigated the effect of IGF-1 on the expression of cyclin D1, an important cell cycle regulatory protein, and a signaling pathway involved in IGF-1's effect on cyclinD1 expression in FRTL thyroid cells.

Methods:

 

FRTL thyroid cells were treated with IGF-1 or vector control for 24 h. As appropriate to individual experiments, a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, and/or a nuclear factor-kappaB (NF-kappaB) inhibitor, BAY11-7082, were added 1 h prior to IGF-1 treatment. Western blotting was used to detect cyclin D1 protein expression. Immunofluorescence was performed to analyze the expression of IkappaBalpha, an NF-kappaB inhibitory protein. Cell cycle analysis was performed by fluorescence activated cell sorting (FACS).

Results:

 

IGF-1 increased the cyclin D1 expression in thyroid cells. This increase was blocked by pretreatment with LY294002 or BAY11-7082. Further studies showed that IGF-1 specifically induced NF-kappaB activity. Treatment with IGF-1 could accelerate cell cycle progression from G0/G1 to S phase, whereas this progression was inhibited by the presence of LY294002 or BAY11-7082.

Conclusion:

 

In summary, the results of the present study show that in FRTL cells, IGF-1 promotes cell cycle progression via an upregulation of cyclin D1 expression, at least partially through the PI3K/NF-kappaB signaling pathway.

Keywords:

insulin-like growth factor-1, phosphatidylinositol 3-kinase, nuclear factor- kappaB, cyclin D1

Extra navigation

.

naturejobs

ADVERTISEMENT